The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Communities or affiliates, or any organization with which the presenter is employed or affiliated.
These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, Drug Information Association Inc., DIA and DIA logo are registered trademarks. All other trademarks are the property of their respective owners.
Agenda
Background
Why is drug assessment necessary
How is endpoint adjudication managed today
How can we make it more efficient
Background
Focus of many pharmaceutical companies today is creating treatments for chronic conditions and diseases.
This shift results in:
Increase in development times and cost
Requirement of long term data to assess benefits and risks
Endpoint driven studies
Why is drug assessment necessary?
Allow regulatory authorities to monitor effect of the intervention on an ongoing basis
ensure drug or device safety
more sound and effective clinical trials
Who generally assesses these endpoints?
Clinical Endpoint Committees (CEC)
Unbiased reviewers
How is endpoint adjudication managed today?
Source Data Collection
Send items to Clinical Project team
Report endpoint
Identify documents that need translation and submit to vendor
Issue and resolve query for missing or incomplete items
Compile endpoint package
Submit to CEC
Review package
Issue and resolve query
Complete adjudication
How can we make it more efficient? Go Paperless
Drawbacks to Paper
No centralized location for packages
Documents need to be shipped to and from several parties including: site, CRO, Translations team, Adjudicators
Slow work flow, frequent duplication
Adjudication results recorded on paper CRF need to be shipped to CRO and or Sponsor to identify patterns
Electronic Enhancements
One seamless portal, easy communication and sharing of documentation
Documents move from one party to the next in a single electronic platform
Decrease processing time and avoid duplicates with electronic identifiers
Adjudication completed on same electronic platform and results are visible immediately
30% Decrease in Endpoint and Package Processing Time by CRO
75% Reduction in Translation Turnaround Time
90% Decrease in Shipping Costs
Additional benefits of Electronic Adjudication
Allows Sponsor to design their own unique workflow
Immediate reconciliation with EDC
Easy access for international teams
Data allows for power calculations, periodic safety reviews by Data Safety Monitoring Boards, sample-size re-estimation and other interim analyses, overall results for efficacy and safety analyses